MMI 📈 Marcus & Millichap - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5663241090
MMI: Real Estate, Financing, Research, Advisory Services
Marcus & Millichap, Inc., an investment brokerage company, provides real estate investment brokerage and financing services to sellers and buyers of commercial real estate in the United States and Canada. The company offers commercial real estate investment sales, financing, research, and advisory services for multifamily, retail, office, industrial, single-tenant net lease, seniors housing, self-storage, hospitality, medical office, and manufactured housing, as well as capital markets. It also operates as a financial intermediary that provides commercial real estate capital markets solutions, including senior debt, mezzanine debt, joint venture, and preferred equity, as well as loan sales and consultative/due diligence services to commercial real estate owners, developers, investors, and capital providers. In addition, the company provides research, advisory, and consulting services, which include opinions of value, operating and financial performance benchmarking analysis, specific asset buy-sell strategies, market and submarket analysis and ranking, portfolio strategies by property type, market strategy, development and redevelopment feasibility studies, and other services for developers, lenders, owners, real estate investment trusts, high-net-worth individuals, pension fund advisors, and other institutions. Marcus & Millichap, Inc. was founded in 1971 and is headquartered in Calabasas, California. Web URL: https://www.marcusmillichap.com
Additional Sources for MMI Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MMI Stock Overview
Market Cap in USD | 1,615m |
Sector | Real Estate |
Industry | Real Estate Services |
GiC Sub-Industry | Real Estate Development |
IPO / Inception | 2013-10-31 |
MMI Stock Ratings
Growth 5y | 17.2% |
Fundamental | -61.5% |
Dividend | 3.78% |
Rel. Strength Industry | -210 |
Analysts | 1/5 |
Fair Price Momentum | 34.49 USD |
Fair Price DCF | - |
MMI Dividends
Dividend Yield 12m | 1.32% |
Yield on Cost 5y | 1.43% |
Annual Growth 5y | -29.29% |
Payout Consistency | 82.5% |
MMI Growth Ratios
Growth Correlation 3m | 55.9% |
Growth Correlation 12m | 40.3% |
Growth Correlation 5y | 26.4% |
CAGR 5y | 1.70% |
CAGR/Mean DD 5y | 0.07 |
Sharpe Ratio 12m | -0.29 |
Alpha | -39.11 |
Beta | 1.21 |
Volatility | 32.19% |
Current Volume | 507.8k |
Average Volume 20d | 99k |
What is the price of MMI stocks?
As of December 22, 2024, the stock is trading at USD 37.99 with a total of 507,826 shares traded.
Over the past week, the price has changed by -5.21%, over one month by -5.33%, over three months by -4.60% and over the past year by -7.08%.
As of December 22, 2024, the stock is trading at USD 37.99 with a total of 507,826 shares traded.
Over the past week, the price has changed by -5.21%, over one month by -5.33%, over three months by -4.60% and over the past year by -7.08%.
Is Marcus & Millichap a good stock to buy?
No, based on ValueRay Fundamental Analyses, Marcus & Millichap (NYSE:MMI) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -61.45 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MMI as of December 2024 is 34.49. This means that MMI is currently overvalued and has a potential downside of -9.21%.
No, based on ValueRay Fundamental Analyses, Marcus & Millichap (NYSE:MMI) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -61.45 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MMI as of December 2024 is 34.49. This means that MMI is currently overvalued and has a potential downside of -9.21%.
Is MMI a buy, sell or hold?
Marcus & Millichap has received a consensus analysts rating of 1.00. Therefor, it is recommend to sell MMI.
Marcus & Millichap has received a consensus analysts rating of 1.00. Therefor, it is recommend to sell MMI.
- Strong Buy: 0
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 1
What are the forecast for MMI stock price target?
According to ValueRays Forecast Model, MMI Marcus & Millichap will be worth about 38.5 in December 2025. The stock is currently trading at 37.99. This means that the stock has a potential upside of +1.24%.
According to ValueRays Forecast Model, MMI Marcus & Millichap will be worth about 38.5 in December 2025. The stock is currently trading at 37.99. This means that the stock has a potential upside of +1.24%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 30 | -21% |
Analysts Target Price | 20 | -47.4% |
ValueRay Target Price | 38.5 | 1.2% |